Global Consumer Healthcare Market

Consumer Healthcare Market Size, Share, Growth Analysis, By Product(OTC Pharmaceuticals, Personal Care Products, Dietary Supplements), By Distribution Channel(Online, Offline (Supermarkets and Hypermarkets, Pharmacies, Others)), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2021 | Region: Global | Published Date: September, 2024
Pages: 219 | Tables: 187 | Figures: 82

Consumer Healthcare Market Competitive Landscape

The state of competition in the global consumer healthcare market involves both the presence of well-established global companies as well as new entrants with promising product innovations. Henry Schein, Inc., Procter & Gamble, GlaxoSmithKline and Bayer are some of the prominent players commanding the market by virtue of strong research and development, wide distribution, and effective promotion. In addition, increasing consumer propensity towards natural & organic products has opened doors for niche brand competition which in turn increases innovation and the range of available products within the industry.

Consumer Healthcare Market Top Players Company Profiles

  • Teva Pharmaceutical Industries Limited (Israel) 
  • Abbott Laboratories (US) 
  • GlaxoSmithKline plc (UK) 
  • Sanofi S.A. (France) 
  • BASF SE (Germany) 
  • Boehringer Ingelheim International GmbH (Germany) 
  • Amway Corp. (US) 
  • Pfizer Inc. (US) 
  • Bayer AG (Germany) 
  • Johnson & Johnson (US) 
  • Reckitt Benckiser Group plc (UK) 
  • Nestle Health Science (Switzerland) 
  • Procter & Gamble Co. (US) 
  • Unilever plc (UK) 
  • Novartis AG (Switzerland) 
  • Herbalife Nutrition Ltd. (US) 
  • DSM Nutritional Products (Netherlands) 
  • Himalaya Global Holdings Ltd. (India) 
  • Perrigo Company plc (Ireland) 
  • Merck KGaA (Germany) 
  • Dabur India Ltd. (India) 
  • Sun Pharmaceutical Industries Ltd. (India)

Recent Developments in Global Consumer Healthcare Market

  • In September 2023, in a recent announcement, Johnson & Johnson proclaimed the introduction of a new line of pain relief products that would be available over the counter and that would contain avant-garde and non-addictive blends. This initiative is designed to meet the increasing consumer demand for effective pain relief measures and still protect the users from dependency on such measures, a clear demonstration of the firm’s principles about responsible care. 
  • In October 2023, Bayer with its consumer healthcare division launched a new range of natural skincare products, focusing on clean formulations. Such initiatives are in response to the growing consumer trends on sustainability and use of organic ingredients in products making it easy for Bayer to deal with health-conscious active trends in the market. 
  • In August 2023, GlaxoSmithKline announced the acquisition of a well-known vitamin and supplements brand to bolster its consumer healthcare portfolio, thereby making strides in the booming dietary supplements sector. This strategy is aimed at bankrolling the strong equity and customer loyalty the brand has built to capitalize on and address the shift of consumer trends toward health.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Consumer Healthcare Market size was valued at USD 281 billion in 2022 and is poised to grow from USD 302.36 billion in 2023 to USD 543.27 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).

The state of competition in the global consumer healthcare market involves both the presence of well-established global companies as well as new entrants with promising product innovations. Henry Schein, Inc., Procter & Gamble, GlaxoSmithKline and Bayer are some of the prominent players commanding the market by virtue of strong research and development, wide distribution, and effective promotion. In addition, increasing consumer propensity towards natural & organic products has opened doors for niche brand competition which in turn increases innovation and the range of available products within the industry. 'Teva Pharmaceutical Industries Limited (Israel) ', 'Abbott Laboratories (US) ', 'GlaxoSmithKline plc (UK) ', 'Sanofi S.A. (France) ', 'BASF SE (Germany) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'Amway Corp. (US) ', 'Pfizer Inc. (US) ', 'Bayer AG (Germany) ', 'Johnson & Johnson (US) ', 'Reckitt Benckiser Group plc (UK) ', 'Nestle Health Science (Switzerland) ', 'Procter & Gamble Co. (US) ', 'Unilever plc (UK) ', 'Novartis AG (Switzerland) ', 'Herbalife Nutrition Ltd. (US) ', 'DSM Nutritional Products (Netherlands) ', 'Himalaya Global Holdings Ltd. (India) ', 'Perrigo Company plc (Ireland) ', 'Merck KGaA (Germany) ', 'Dabur India Ltd. (India) ', 'Sun Pharmaceutical Industries Ltd. (India)', 'In September 2023, in a recent announcement, Johnson & Johnson proclaimed the introduction of a new line of pain relief products that would be available over the counter and that would contain avant-garde and non-addictive blends. This initiative is designed to meet the increasing consumer demand for effective pain relief measures and still protect the users from dependency on such measures, a clear demonstration of the firm’s principles about responsible care. ', 'In October 2023, Bayer with its consumer healthcare division launched a new range of natural skincare products, focusing on clean formulations. Such initiatives are in response to the growing consumer trends on sustainability and use of organic ingredients in products making it easy for Bayer to deal with health-conscious active trends in the market. ', 'In August 2023, GlaxoSmithKline announced the acquisition of a well-known vitamin and supplements brand to bolster its consumer healthcare portfolio, thereby making strides in the booming dietary supplements sector. This strategy is aimed at bankrolling the strong equity and customer loyalty the brand has built to capitalize on and address the shift of consumer trends toward health.'

The improvement of consumer attitude regarding health and wellness is among the factors responsible for the growth of the global consumer healthcare market. As people understand more about preventive health care and self-care, they begin to reach out for non-prescription medicines and nutritional health products which in turn facilitates the expansion of the market and the rise in the variety of products sold in the market. 

Growing Demand for Personalization: There is a growing trend within the global consumer healthcare market in favor of health offerings that are based on the specific needs and diversity of everyone. Organizations are capitalizing on data analytics combined with technology to come up with specific heath regimens, targeted food supplements among other services that focus on addressing specific health needs making clients happy and loyal from within. 

North America dominates the global consumer healthcare market due to its advanced healthcare infrastructure, high disposable income, and increasing consumer awareness of health and wellness. The region enjoys a fully functioning system of retail and online distribution channels enabling accessibility to a variety of healthcare products. Moreover, safety and efficacy concerns about the products are addressed by the existing legal structures, thus promoting trust amongst consumers. With the rising risk factors of the population leading to improvements in self-medication and preventive health care coupled with effective marketing campaigns by the major players, the North American market continues to grow thus maintaining its dominance in the global consumer healthcare market. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Consumer Healthcare Market

Report ID: SQMIG35D2021

$5,300
BUY NOW GET FREE SAMPLE